As Florida's pivotal vote on recreational cannabis looms, investors are eyeing key opportunities in the market. The Viridian Credit Tracker ranks AYR Wellness (OTC:AYRWF) as a strong buy, with a compelling 20% yield driven by its significant presence in Florida's cannabis market. With the potential for Florida voters to approve recreational use, AYR stands to gain considerably, making it a prime target for investors before the vote.
- Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter here. You can't afford to miss out if you're serious about the business.
AYR Wellness Offers 20% Yield: Capitalize on Florida's Potential Vote
According to the Viridian Credit Tracker from Viridian Capital Advisors, AYR's exposure to Florida's market gives it a unique advantage ahead of the state's potential legalization of recreational cannabis.
With a 20% trading yield, AYR outpaces many of its competitors. If Florida approves recreational cannabis, AYR's valuation could see a substantial boost, making this stock a strategic buy for investors ahead of the vote.
Cresco Labs vs. Curaleaf: A 250 Basis Point Difference
Another suggested pair trade from the report is to buy Cresco Labs (OTC:CRLBF) at a 12.6% yield and sell Curaleaf (OTC:CURLF) at 10.1%. This trade offers investors a 250 basis point yield upgrade, backed by Cresco's solid financials and credit improvement. Investors looking for higher returns and credit strength should consider this opportunity.
Read Also: EXCLUSIVE: 80% Growth Despite The Chaos: How Dutchie, C3 Defy 2024's Cannabis Slump
TerrAscend: Why 12% Yield Might Not Be Enough
In contrast, TerrAscend (OTC:TRSSF), which offers a 12% yield, is recommended as a sell. While TerrAscend remains a significant player in the cannabis industry, its lower yield and reduced exposure to Florida's growth potential make it less appealing compared to AYR.
Cannabist Faces Liquidity Challenges
Despite the attractive spreads among top stocks, Cannabist (OTC:CCHWF) ranks as the weakest credit in the group, largely due to liquidity concerns following recent asset sales. Investors should note that Cannabist's lower credit rating may limit its near-term upside despite potential improvements in the future.
Take Action Now: Florida's Vote Could Change the Game
With Florida's cannabis market potentially expanding, investors looking to maximize gains should consider this pair trade: buy AYR at 20%, sell TerrAscend at 12%, and look into Cresco Labs at 12.6% versus Curaleaf at 10.1%. The vote could transform the landscape for cannabis stocks, and taking action before this pivotal event could provide substantial returns.
Courtesy of Viridian Capital Advisors 随着佛罗里达对休闲大麻的关键表决临近,投资者正关注市场中的关键机会。 Viridian信贷追踪器将AYR Wellness(场外交易:AYRWF)评为强劲买入,强调其在佛罗里达大麻市场上的重要存在,带来令人信服的20%收益。如果佛罗里达选民批准休闲使用,AYR将大幅获益,使其成为投资者在表决前的首要目标。
- 在Benzinga获取独家分析,并每天免费获得关于大麻业务和市场的头条新闻。立即订阅我们的通讯,认真对待业务,您不容错过。
AYR Wellness提供20%的收益:利用佛罗里达的潜在投票机会
根据Viridian Capital Advisors的Viridian信贷追踪器显示,AYR对佛罗里达市场的敞开态度使其在该州潜在合法化休闲大麻之前就已具备独特优势。
拥有20%的交易收益,AYR超越了许多竞争对手。如果佛罗里达批准休闲大麻,AYR的估值可能会大幅提升,这使得该股成为投资者在投票前的战略性买入。
Cresco Labs对比Curaleaf:250个基点的差异
报告另一个建议的配对交易是买入Cresco Labs(场外交易:CRLBF),收益率为12.6%,卖出Curaleaf(场外交易:CURLF),收益率为10.1%。此交易为投资者提供250个基点的出厂升级,得到Cresco稳健的财务状况和信用改善的支持。寻求更高回报和信用强度的投资者应考虑这一机会。
阅读更多:独家报道:尽管混乱,Dutchie、C3仍然实现了80%的增长:如何抵御2024年的大麻低迷
TerrAscend:为什么12%的收益可能不够
相比之下,推荐卖出大麻股TerrAscend(场外交易代码:TRSSF),提供12%的收益。尽管TerrAscend在大麻行业中仍然是一个重要的参与者,但其较低的收益率和对佛罗里达州增长潜力的减少暴露使其与AYR相比显得不那么吸引人。
大麻板块面临流动性挑战
尽管各大股票之间利差吸引人,但大麻股Cannabist(场外交易代码:CCHWF)被评为该组中信用最弱的股票,这主要是由于近期资产销售后对流动性的担忧。投资者应注意,尽管未来有可能改善,Cannabist较低的信用评级可能限制其近期的上升空间。
立即行动:佛罗里达的选举可能改变游戏规则
随着佛罗里达的大麻市场有望扩大,希望最大化收益的投资者应考虑这一交易组合:买入AYR股票20%,卖出TerrAscend股票12%,并关注Cresco Labs股票12.6%对比Curaleaf股票10.1%。该选举可能改变大麻股的局势,在这一关键事件发生前采取行动可能带来可观的回报。
由Viridian Capital Advisors 提供